ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1,4,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1,9,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1,10,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1,11,Upper-airway cough syndrome,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
4,2,Wound infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
5,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6,1,Genital herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
7,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,4,Enlarged uvula,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
7,5,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
7,6,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
7,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
7,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
9,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
9,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
9,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
9,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,7,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
9,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
9,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9,10,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
9,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9,13,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,14,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
11,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
11,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
12,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
13,1,Headache,Headaches NEC,Headaches,Nerv,N
13,2,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
13,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
13,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
14,2,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
14,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,4,Stenosis,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,1,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
15,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
15,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
15,4,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
15,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
16,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
16,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
17,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
17,2,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
18,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
19,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
19,2,False positive investigation result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
20,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
20,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
21,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
22,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
22,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
23,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
24,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
25,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
27,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
27,4,Type III immune complex mediated reaction,Allergic conditions NEC,Allergic conditions,Immun,N
27,5,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
28,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
29,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
29,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
29,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,4,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,6,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
30,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
31,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
32,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
32,2,Headache,Headaches NEC,Headaches,Nerv,N
32,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
33,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
34,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
34,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
34,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
34,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
35,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
36,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
36,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
36,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
36,4,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
37,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
38,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
38,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
38,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
38,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
39,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
40,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
41,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
42,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
43,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
43,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
43,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
43,5,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
44,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
45,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
45,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
46,1,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
46,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
46,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
47,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
48,1,Pyogenic granuloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
49,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
50,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
50,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
50,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
50,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
50,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
51,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
52,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
52,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
52,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
52,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
52,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
52,6,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
53,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
54,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
54,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
55,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
55,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
56,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
56,3,Pleural mesothelioma malignant,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
57,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
57,2,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
58,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
58,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
60,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
60,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
60,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
60,4,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
60,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
60,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
60,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
60,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
60,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
61,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
62,1,Acne,Acnes,Skin appendage conditions,Skin,N
62,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
63,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
63,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
63,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
64,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
64,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
64,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
64,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
65,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
66,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
66,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
67,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
67,3,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
67,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
68,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
69,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
69,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
70,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
70,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
70,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
70,4,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
71,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
71,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
71,3,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
72,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
72,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
72,3,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
72,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
72,5,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
73,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
74,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
74,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
74,4,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
74,5,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
74,6,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
74,7,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
74,8,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
74,9,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
74,10,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
74,11,Nasal discharge discolouration,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
74,12,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
74,13,Noninfective conjunctivitis,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
74,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
74,15,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
74,16,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
75,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
75,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
75,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
75,4,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
75,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
75,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
76,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
78,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
78,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
78,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
78,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
78,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
79,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
79,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
79,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
80,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
80,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
80,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
80,4,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
80,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
80,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
80,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
80,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
80,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,10,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
80,11,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,12,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,13,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,14,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
81,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
81,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
82,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
83,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
83,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
83,3,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
83,4,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
83,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
83,6,Oropharyngeal blistering,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
84,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
85,1,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
85,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
86,1,Deafness,Hearing losses,Hearing disorders,Ear,N
86,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
86,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
87,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
87,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
87,3,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
87,4,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
87,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
87,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
88,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
88,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
88,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
89,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
90,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
90,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
91,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
91,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
91,3,Headache,Headaches NEC,Headaches,Nerv,N
91,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
91,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
91,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
91,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
92,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
92,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
93,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
93,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
93,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
93,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
93,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
93,6,Headache,Headaches NEC,Headaches,Nerv,N
93,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
94,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
95,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
95,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
95,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
95,4,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
96,1,Anticoagulation drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
96,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
98,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
99,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
99,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
99,3,Plantar fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
99,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
100,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
101,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
102,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
102,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
103,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
104,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
105,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
106,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
106,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
106,3,Headache,Headaches NEC,Headaches,Nerv,N
106,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
106,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
107,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
108,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
108,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
108,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
109,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
110,1,Anticoagulation drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
110,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
110,4,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
111,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
112,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
112,2,Headache,Headaches NEC,Headaches,Nerv,N
113,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
113,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
113,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
113,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
113,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
113,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
113,7,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
114,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
115,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
116,1,Episcleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
116,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
117,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
118,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
118,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
118,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
119,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
120,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
122,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
123,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
123,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
123,4,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
124,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
125,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
126,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
126,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
126,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
126,4,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
126,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
126,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
126,7,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
126,8,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
126,9,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
126,10,Normal pressure hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
126,11,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
126,12,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
126,13,Varicose veins of abdominal wall,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
127,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
127,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
127,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
127,4,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
127,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
128,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
129,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
129,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
129,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
129,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
131,1,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
132,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
133,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
133,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
133,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
133,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
133,5,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
134,1,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
134,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
135,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
136,1,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
136,2,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
137,1,Dermatopathic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
137,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
137,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
137,4,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
137,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
137,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
137,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
137,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,9,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
138,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
138,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
138,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
138,4,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
138,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
138,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
138,7,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
139,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
139,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
139,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
140,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
140,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
140,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
141,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
141,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
141,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
142,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
142,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
142,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
142,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
142,5,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
143,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
143,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
143,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
143,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
144,1,Peripheral venous disease,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
145,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
146,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
147,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
147,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
147,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
147,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
147,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
147,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
147,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
148,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
148,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
148,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
148,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
148,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
148,6,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
149,1,Genital blister,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
150,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
150,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
150,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
151,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
151,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
151,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
152,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
153,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
154,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
155,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
156,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
157,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
157,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
157,3,Rectal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
158,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
158,2,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
159,1,Episcleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
160,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
160,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
160,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
160,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
161,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
162,1,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
163,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
163,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
163,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
164,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
165,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
166,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
167,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
168,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
169,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
170,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
170,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
170,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
170,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
170,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
170,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
171,1,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
172,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
172,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
172,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
173,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
173,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
173,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
173,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
174,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
174,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
174,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
174,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
174,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
174,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
175,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
175,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
176,1,Germ cell neoplasm,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
176,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
177,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
178,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
178,2,Depressive symptom,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
178,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
179,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
180,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
180,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
180,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
180,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
180,5,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
181,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
182,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
182,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
183,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
184,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
185,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
186,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
186,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
187,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
188,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
189,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
189,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
189,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
189,4,Genital blister,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
189,5,Vertigo positional,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
190,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
191,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
191,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
192,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
192,2,Headache,Headaches NEC,Headaches,Nerv,N
192,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
193,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
193,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
194,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
194,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
194,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
195,1,Headache,Headaches NEC,Headaches,Nerv,N
195,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
196,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
197,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
198,1,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
198,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
199,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
200,1,Acne,Acnes,Skin appendage conditions,Skin,N
200,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
200,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
200,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
200,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
200,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
201,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
201,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
201,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
201,5,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
201,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
202,1,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
202,2,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
203,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
203,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
203,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
204,1,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
205,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
206,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
206,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
207,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
207,2,Device issue,Device issues NEC,Device issues,Prod,N
207,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
207,4,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
207,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
208,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
209,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
209,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
210,1,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
210,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
211,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
211,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
211,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
212,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
212,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
213,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
213,2,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
213,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
214,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
215,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
216,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
217,1,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
217,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
217,3,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
217,4,Skin candida,Candida infections,Fungal infectious disorders,Infec,N
218,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
218,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
219,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
219,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
220,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
220,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
220,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
220,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
220,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
221,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
222,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
222,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
222,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
223,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
224,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
225,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
226,1,Coating in mouth,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
226,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
226,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
226,4,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
226,5,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
227,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
228,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
229,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
229,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
229,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
229,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
229,5,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
229,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
229,7,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
230,1,Brain neoplasm benign,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
231,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
232,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
233,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
233,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
233,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
234,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
235,1,Allergic oedema,Allergic conditions NEC,Allergic conditions,Immun,N
235,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
235,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
235,4,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
235,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
235,6,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
235,7,Oropharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
235,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
235,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
235,10,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
235,11,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
235,12,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
235,13,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
235,14,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
235,15,Upper airway obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
236,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
237,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
237,2,Headache,Headaches NEC,Headaches,Nerv,N
237,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
238,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
238,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
239,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
240,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
240,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
240,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
241,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
242,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
243,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
243,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
245,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
245,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
245,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
246,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,2,Headache,Headaches NEC,Headaches,Nerv,N
246,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
246,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
247,1,Autoimmune thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
247,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
248,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
248,2,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
248,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
248,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
249,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
250,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
250,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
250,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
250,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
250,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
251,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
252,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
253,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
254,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
254,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
254,3,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
255,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
255,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
255,3,Oropharyngeal plaque,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
256,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
257,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
258,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
258,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
258,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
259,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
260,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
261,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
262,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
263,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
263,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
263,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
263,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
264,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
264,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
265,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
265,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
266,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
266,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
267,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
267,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
268,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
268,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
268,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
269,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
269,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
269,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
270,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
270,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
270,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
270,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
270,5,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
271,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
272,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
273,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
274,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
274,2,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
275,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
275,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
275,3,Plague,Yersinia infections,Bacterial infectious disorders,Infec,N
276,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
276,2,Headache,Headaches NEC,Headaches,Nerv,N
276,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
277,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
278,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
279,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
279,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
280,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
281,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
282,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
283,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
283,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
284,1,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
284,2,Vaginal prolapse,Pelvic prolapse conditions,"Uterine, pelvic and broad ligament disorders",Repro,N
285,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
286,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
286,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
287,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
287,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
288,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
288,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
288,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
289,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
289,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
289,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
290,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
291,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
291,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
291,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
291,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
291,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
291,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
291,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
291,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
291,9,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
292,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
293,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
294,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
294,2,Relapsing multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
295,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
296,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
296,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
297,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
298,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
299,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
300,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
301,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
301,2,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
301,3,Pathological fracture,Fractures NEC,Fractures,Musc,N
302,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
303,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
304,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
305,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
306,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
307,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
308,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
309,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
309,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
310,1,Germ cell cancer,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
310,2,Mediastinal mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
311,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
312,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
313,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
313,2,Headache,Headaches NEC,Headaches,Nerv,N
313,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
314,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
315,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
315,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
315,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
316,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
317,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
318,1,Angiomyolipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
319,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
319,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
319,3,Non-small cell lung cancer recurrent,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
320,1,Axillary lymphadenectomy,Breast therapeutic procedures NEC,Breast therapeutic procedures,Surg,N
320,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
321,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
321,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
321,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
321,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
321,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
321,7,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
321,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
321,9,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
321,10,Oropharyngeal blistering,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
321,11,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
321,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
322,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
323,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
323,2,Splenic injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
324,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
325,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
326,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
327,1,Scleroderma-like reaction,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
328,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
328,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
328,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
329,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
329,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
330,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
331,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
332,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
332,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
332,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
332,5,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
332,6,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
333,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
333,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
334,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
334,2,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
335,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
335,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
336,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
337,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
338,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
339,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
339,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
339,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
340,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
340,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
340,3,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
340,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
341,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
342,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
342,2,Pneumonia klebsiella,Klebsiella infections,Bacterial infectious disorders,Infec,N
342,3,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
343,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
344,1,Hypersensitivity vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
345,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
345,2,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
345,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
345,4,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
346,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
347,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
347,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
347,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
348,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
348,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
348,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
348,4,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
348,5,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
348,6,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
348,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
349,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
349,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
349,3,Free fatty acids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
349,4,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
350,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
350,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
350,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
350,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
350,5,Peripancreatic fluid collection,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
350,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
351,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
352,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
352,2,Connective tissue disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
353,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
353,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
354,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
355,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
355,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
356,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
356,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
357,1,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
358,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
358,2,Exposure via partner,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
359,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
359,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
360,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
361,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
362,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
362,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
362,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
362,4,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
363,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
364,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
364,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
365,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
365,2,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
365,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
365,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
365,5,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
366,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
367,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
367,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
367,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
368,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
369,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
370,1,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
370,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
371,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
372,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
372,2,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
373,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
373,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
373,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
373,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
373,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
373,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
374,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
375,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
376,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
376,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
377,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
378,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
379,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
380,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
381,1,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
382,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
382,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
382,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
383,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
383,2,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
384,1,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
384,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
385,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
386,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
387,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
388,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
389,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
389,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
389,3,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
390,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
391,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
391,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
391,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
391,4,Nasal mucosal erosion,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
391,5,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
391,6,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
391,7,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
392,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
392,2,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
392,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
392,4,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
392,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
393,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
394,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
395,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
396,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
396,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
397,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
397,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,3,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
398,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
399,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
399,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
399,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
399,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
399,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
400,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
400,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
400,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
400,4,Proctitis ulcerative,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
400,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
401,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
401,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
402,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
402,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
402,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
402,4,Proctitis ulcerative,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
402,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
403,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
403,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
403,3,Intervertebral disc disorder,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
403,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
404,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
404,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
404,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
405,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
406,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
407,1,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
408,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
408,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
408,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
408,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
409,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
409,2,Basophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
409,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
409,4,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
409,5,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
409,6,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
409,7,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
409,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
409,9,Mean cell haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
409,10,Mean cell volume decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
409,11,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
409,12,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
410,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
411,1,Penile cancer,Penile neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
412,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
413,1,Cutaneous T-cell lymphoma stage I,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
413,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,3,Lymphocyte morphology abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
413,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
413,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
413,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
414,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
414,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
414,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
414,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
414,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
414,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
414,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
414,8,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
414,9,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
414,10,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
415,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
415,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
416,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
416,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
416,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
417,1,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
417,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
417,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
418,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
419,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
419,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
420,1,Peutz-Jeghers syndrome,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
421,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
421,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
421,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
421,4,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
421,5,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
421,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
422,1,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
422,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
422,3,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
423,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
424,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
424,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
424,3,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
425,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
426,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
426,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
426,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
427,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
427,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
427,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
428,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
428,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
428,3,Headache,Headaches NEC,Headaches,Nerv,N
428,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
429,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
430,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
430,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
430,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
431,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
432,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
432,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
432,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
432,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
432,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
433,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
433,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
433,3,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
433,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
433,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
433,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
433,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
433,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
433,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
433,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
433,11,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
433,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
434,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
435,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
435,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
435,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
435,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
435,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
435,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
436,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
437,1,Cystitis noninfective,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
438,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
439,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
439,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
439,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
440,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
440,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
440,3,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
440,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
441,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
442,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
442,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
442,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
442,4,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
443,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
443,2,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
443,3,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
443,4,Graft infection,Infections NEC,Infections - pathogen unspecified,Infec,N
443,5,Klebsiella bacteraemia,Klebsiella infections,Bacterial infectious disorders,Infec,N
443,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
443,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
443,8,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
444,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
444,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
444,3,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
444,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
445,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
445,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
446,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
447,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
447,2,Headache,Headaches NEC,Headaches,Nerv,N
447,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
448,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
448,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
448,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
448,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
448,5,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
448,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
449,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
449,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
449,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
449,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
450,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
451,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
451,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
451,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
452,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
452,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
453,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
453,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
454,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
455,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
455,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
456,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
456,2,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
456,3,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
456,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
456,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
456,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
457,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
457,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
457,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
457,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
458,1,Burn oral cavity,Thermal burns,Injuries by physical agents,Inj&P,N
458,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
458,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
458,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
458,5,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
458,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
458,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
458,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
458,9,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
459,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
459,2,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
459,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
459,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
459,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
459,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
460,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
461,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
462,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
462,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
462,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
462,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
463,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
463,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
463,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
464,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
465,1,Headache,Headaches NEC,Headaches,Nerv,N
465,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
465,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
465,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
466,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
467,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
468,1,Headache,Headaches NEC,Headaches,Nerv,N
468,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
468,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
468,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
469,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
470,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
471,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
472,1,Chondrosarcoma,Cartilage sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
473,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
474,1,Chondrosarcoma,Cartilage sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
475,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
476,1,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
476,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
476,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
476,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
476,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
476,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
476,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
476,8,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
476,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
477,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
478,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
478,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
479,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
479,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
479,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
479,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
479,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
479,6,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
480,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
481,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
482,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
483,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
484,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
484,2,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
485,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,Y
486,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
487,1,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
488,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
488,2,Aortic valve disease,Aortic valvular disorders,Cardiac valve disorders,Card,N
488,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
488,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
488,5,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
488,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
488,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
488,8,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
488,9,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
488,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
488,11,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
488,12,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
488,13,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
488,14,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
488,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
488,16,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
488,17,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
489,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
490,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
491,1,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
492,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
492,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
493,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
494,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
495,1,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
496,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
496,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
496,3,Perforation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
497,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
497,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
497,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
498,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
498,2,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
498,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
499,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
500,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
500,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
500,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
501,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
502,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
502,2,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
503,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
504,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
505,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
506,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
506,2,Dactylitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
506,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
506,5,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
506,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
506,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
506,8,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
506,9,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
506,10,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
506,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
506,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
506,13,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
506,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
506,15,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
506,16,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
507,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
508,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
509,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
509,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
510,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
511,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
511,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
512,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
513,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
513,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
513,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
513,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
513,5,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
513,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
513,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
513,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
513,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
513,10,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
513,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
514,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
514,2,Postpartum disorder,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
514,3,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
515,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
515,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
515,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
515,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
515,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
516,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
516,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
516,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
517,1,Abscess intestinal,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
517,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
517,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
518,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
518,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
519,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
520,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
521,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
521,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
522,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
522,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
522,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
522,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
522,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
522,6,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
523,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
524,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
524,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
524,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
524,4,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
524,5,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
525,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
525,2,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
526,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
527,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
528,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
528,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
528,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
529,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
529,2,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
529,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
530,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
531,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
531,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
531,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
531,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
531,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
532,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
533,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
534,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
535,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
535,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
536,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
536,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
536,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
537,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
537,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
538,1,Bone loss,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
538,2,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
538,3,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
539,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
540,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
540,2,Prostatic abscess,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
540,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
541,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
541,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
542,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
542,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
542,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
543,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
543,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
543,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
543,4,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
544,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
545,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
545,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
545,3,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
545,4,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
546,1,Headache,Headaches NEC,Headaches,Nerv,N
546,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
546,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
546,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
546,5,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
547,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
548,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
548,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
548,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
549,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
550,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
551,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
551,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
552,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
552,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
552,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
552,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
552,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,6,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
552,7,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
552,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
552,9,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
552,10,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
552,11,Meniscus injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
552,12,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
552,13,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
552,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
552,15,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
552,16,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
552,17,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
552,18,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
552,19,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
552,20,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,21,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,22,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
553,1,Meniere's disease,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
554,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
555,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
556,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
556,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
556,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
557,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
558,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
559,1,Dactylitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
559,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
559,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
559,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
559,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
560,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
560,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
561,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
561,2,Prostatic abscess,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
561,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
562,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
562,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
562,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
562,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
562,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
562,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
562,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
562,8,Manufacturing product shipping issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
562,9,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
563,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
564,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
564,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
564,3,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
565,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
565,2,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
565,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
565,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
565,5,Pregnancy on contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
565,6,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
566,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
566,2,Meibomian gland dysfunction,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
567,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
568,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
569,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
570,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
570,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
570,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
570,4,Pregnancy on contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
570,5,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
571,1,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
571,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
571,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
572,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
573,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
574,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
574,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
575,1,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
576,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
576,2,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
576,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
576,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
577,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
578,1,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
579,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
579,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
580,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
581,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
582,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
583,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
584,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
585,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
585,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
586,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
586,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
587,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
588,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
588,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
588,3,SARS-CoV-2 antibody test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
589,1,Onychomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
590,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
590,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
590,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
590,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
591,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
591,2,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
592,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
593,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
594,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
595,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
595,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
596,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
597,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
598,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
598,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
598,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
599,1,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
599,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
600,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
601,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
602,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
603,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
603,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
603,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
604,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
605,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
606,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
607,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
608,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
609,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
609,2,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
609,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
609,4,Nasal ulcer,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
610,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
611,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
611,2,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
611,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
611,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
611,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
611,6,Plasma cell leukaemia,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
612,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
612,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
613,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
613,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
613,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
613,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
613,5,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
613,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
614,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
615,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
615,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
615,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
616,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
616,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
618,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
618,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
619,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
619,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
619,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
619,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
620,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
620,2,Device delivery system issue,Device issues NEC,Device issues,Prod,N
620,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
621,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
622,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
622,2,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
622,3,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
622,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
622,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
622,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
622,7,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
623,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
623,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
623,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
624,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
624,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
624,3,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
625,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
626,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
627,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
628,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
629,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
630,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
630,2,Migraine,Migraine headaches,Headaches,Nerv,N
630,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
630,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
631,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
632,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
633,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
633,2,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
634,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
635,1,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
636,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
637,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
638,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
639,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
639,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
639,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
639,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
639,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
639,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
639,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
639,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
640,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
640,2,Hilar lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
640,3,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
640,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
641,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
642,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
643,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
644,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
645,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
645,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
645,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
645,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
645,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
645,6,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
646,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
647,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
648,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
649,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
649,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
650,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
651,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
651,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
651,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
651,4,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
652,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
652,2,Headache,Headaches NEC,Headaches,Nerv,N
652,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
652,4,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
653,1,Leiomyosarcoma metastatic,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
653,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
654,1,Headache,Headaches NEC,Headaches,Nerv,N
654,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
655,1,Headache,Headaches NEC,Headaches,Nerv,N
656,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
656,2,Concomitant disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
656,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
657,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
657,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
657,3,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
658,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
658,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
659,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
660,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
660,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
660,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
661,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
661,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
662,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
662,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
662,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
663,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
663,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
663,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
663,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
663,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
663,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
664,1,Headache,Headaches NEC,Headaches,Nerv,N
664,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
665,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
665,2,Psoriasis area severity index increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
666,1,Biopsy prostate abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
667,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
668,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
668,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
668,3,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
668,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
668,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
669,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
669,2,Foetal heart rate decreased,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
670,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
670,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
670,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
670,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
671,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
671,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
671,3,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
672,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
673,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
674,1,Headache,Headaches NEC,Headaches,Nerv,N
675,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
675,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
675,3,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
676,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
676,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
676,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
677,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
677,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
678,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
678,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
679,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
680,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
680,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
680,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
680,4,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
680,5,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
680,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
680,7,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
680,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
680,9,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
680,10,Inflammation,Inflammations,General system disorders NEC,Genrl,N
680,11,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
680,12,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
680,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
680,14,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
680,15,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
680,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
680,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
680,18,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
680,19,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
680,20,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
681,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
681,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
681,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
681,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
682,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
682,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
682,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
683,1,No reaction on previous exposure to drug,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
684,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
685,1,Psoriasis area severity index,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
686,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
686,2,Acne,Acnes,Skin appendage conditions,Skin,N
686,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
686,4,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
686,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
686,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
686,7,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
686,8,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
686,9,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
686,10,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
686,11,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
687,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
687,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
687,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
687,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
688,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
688,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
689,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
690,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
691,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
691,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
691,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
691,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
691,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
692,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
692,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
693,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
693,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
693,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
693,4,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
694,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
694,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
695,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
695,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
695,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
695,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
695,5,Urinary tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
696,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
697,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
698,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
699,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
700,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
701,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
701,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
701,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
701,4,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
702,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
702,2,Antinuclear antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
702,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
702,4,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
702,5,Bile duct adenocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
702,6,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
702,7,Immunoglobulins increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
702,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
703,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
703,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
703,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
704,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
704,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
704,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
705,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
706,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
706,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
706,3,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
706,4,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
706,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
706,6,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
707,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
707,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
707,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
707,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
707,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
708,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
708,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
708,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
708,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
709,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
710,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
711,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
712,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
712,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
713,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
713,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
713,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
713,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
714,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
715,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
715,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
716,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
717,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
718,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
718,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
718,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
719,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
719,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
720,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
720,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
720,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
720,4,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
720,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
720,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
720,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
721,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
722,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
723,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
723,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
723,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
723,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
723,5,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
723,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
723,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
724,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
724,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
724,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
725,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
725,2,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
726,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
726,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
727,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
728,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
728,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
728,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
728,4,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
728,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
728,6,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
728,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
729,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
730,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
730,2,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
731,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
731,2,Headache,Headaches NEC,Headaches,Nerv,N
731,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
732,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
733,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
734,1,Eczema infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
735,1,Bacterial colitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
736,1,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
737,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
737,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
737,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
737,4,Double stranded DNA antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
737,5,Headache,Headaches NEC,Headaches,Nerv,N
737,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
737,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
737,8,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
737,9,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
737,10,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
737,11,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
737,12,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
737,13,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
737,14,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
737,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
738,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
738,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
739,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
740,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
741,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
742,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
742,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
742,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
743,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
744,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
744,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
744,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
744,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
745,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
746,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
746,2,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
746,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
746,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
746,5,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
746,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
746,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
746,8,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
746,9,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
747,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
748,1,Device delivery system issue,Device issues NEC,Device issues,Prod,N
748,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
748,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
749,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
749,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
749,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
749,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
749,5,Ulcerative duodenitis,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
750,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
750,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
750,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
750,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
750,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
750,6,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
751,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
752,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
752,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
752,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
752,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
752,5,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
752,6,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
752,7,Headache,Headaches NEC,Headaches,Nerv,N
752,8,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
752,9,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
752,10,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
752,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
752,12,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
752,13,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
752,14,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
752,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
752,16,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
752,17,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
752,18,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
752,19,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
752,20,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
752,21,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
753,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
753,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
754,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
754,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
754,3,Nipple exudate bloody,Breast signs and symptoms,Breast disorders,Repro,N
754,4,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
755,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
755,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,1,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
756,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
757,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
758,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
758,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
759,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
759,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
760,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
761,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
761,2,Device leakage,Device issues NEC,Device issues,Prod,N
761,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
761,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
761,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
762,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
762,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
763,1,Device issue,Device issues NEC,Device issues,Prod,N
763,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
764,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
764,2,Drug administered in wrong device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
764,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
764,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
765,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
765,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
765,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
766,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
766,2,Headache,Headaches NEC,Headaches,Nerv,N
766,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
766,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
766,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
767,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
768,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
768,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
769,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,4,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
769,5,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
770,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
770,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
770,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
770,4,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
770,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
770,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
770,7,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
770,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
770,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
770,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
770,11,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
771,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
771,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
772,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
772,2,Prurigo,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
772,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
772,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
773,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
774,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
774,2,Exposure to SARS-CoV-2,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
774,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
774,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
774,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
775,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
775,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
775,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
775,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
775,5,Sputum increased,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
775,6,Sputum purulent,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
775,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
776,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
776,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
777,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
778,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
778,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
778,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
779,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
779,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
779,3,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
780,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
780,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
780,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
781,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
782,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
783,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
783,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
783,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
784,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
785,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
786,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
787,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
788,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
789,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
789,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
789,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
790,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
790,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
790,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
791,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,Y
791,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
792,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
793,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
793,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
794,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
794,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
794,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
795,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
796,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
796,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
797,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
798,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
798,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
799,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
800,1,Ciliary body melanoma,Ocular melanomas,Ocular neoplasms,Neopl,N
800,2,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
801,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
802,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
802,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
802,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
803,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
803,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
804,1,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
804,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
805,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
805,2,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
805,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
805,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
806,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
807,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
808,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
808,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
808,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
809,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
809,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
810,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
810,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
811,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
811,2,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
811,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
812,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
813,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
813,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
814,1,Dental cyst,Dental disorders NEC,Dental and gingival conditions,Gastr,N
815,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
815,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
815,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
815,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
815,5,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
816,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
816,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
816,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
817,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
817,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
817,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
818,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
818,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
818,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
819,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
819,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
819,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
820,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
820,2,Headache,Headaches NEC,Headaches,Nerv,N
820,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
821,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
821,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
821,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
821,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
821,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
822,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
823,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
823,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
823,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
824,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
824,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
825,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
825,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
825,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
826,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
826,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
827,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
828,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
828,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
829,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
829,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
829,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
829,4,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
830,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
831,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
831,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
831,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
831,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
831,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
831,6,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
831,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
831,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
831,9,Migraine,Migraine headaches,Headaches,Nerv,N
831,10,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
831,11,Sinonasal obstruction,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
831,12,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
831,13,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
832,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
832,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
832,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
833,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
833,2,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
834,1,Ileal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
835,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
835,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
836,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
836,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
836,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
837,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
838,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
838,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
838,3,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
839,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
839,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
840,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
841,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
841,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
842,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
842,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
842,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
842,4,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
843,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
843,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
843,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
843,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
843,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
843,6,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
843,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
843,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
843,9,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
843,10,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
843,11,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
843,12,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
843,13,Swollen joint count abnormal,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
843,14,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
843,15,Tender joint count increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
844,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
845,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
845,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
846,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
846,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
846,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
847,1,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
848,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
849,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
850,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
851,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
852,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
852,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
853,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
854,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
854,2,Gastritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
854,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
854,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
854,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
854,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
854,7,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
854,8,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
854,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
854,10,Renal atrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
854,11,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
854,12,Renal hypertrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
854,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
854,14,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
854,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
854,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
855,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
855,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
855,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
856,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
857,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
858,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
859,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
860,1,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
860,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
860,3,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
861,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
861,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
862,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
863,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
863,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
864,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
864,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
864,3,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
865,1,Encephalomyelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
866,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
866,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
866,3,Device failure,Device issues NEC,Device issues,Prod,N
866,4,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
867,1,Maternal exposure via partner during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
868,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
868,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
868,3,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
868,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
868,5,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
869,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
869,2,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
869,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
869,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
870,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
870,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
871,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
871,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
871,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
871,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
872,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
872,2,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
872,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
872,4,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
873,1,Maternal exposure via partner during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
874,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
874,2,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
875,1,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
876,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
877,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
878,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
878,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
878,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
878,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
878,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
878,6,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
878,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
878,8,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
878,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
879,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
879,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
879,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
880,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
880,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
881,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
881,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
881,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
881,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
881,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
881,6,Skin discharge,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
881,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
881,8,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
881,9,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
882,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
882,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,3,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
883,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
884,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
885,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
886,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
886,2,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
886,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
886,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
887,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
888,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
888,2,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
889,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
889,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
890,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
891,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
891,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
893,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
894,1,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
895,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
895,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
896,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
897,1,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
898,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
899,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
900,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
901,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
902,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
903,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
904,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
905,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
905,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
905,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
906,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
906,2,Device issue,Device issues NEC,Device issues,Prod,N
906,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
907,1,Device issue,Device issues NEC,Device issues,Prod,N
907,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
907,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
908,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
908,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
909,1,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
910,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
911,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
912,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
912,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
913,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
913,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
913,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
913,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
913,5,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
913,6,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
913,7,Headache,Headaches NEC,Headaches,Nerv,N
913,8,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
913,9,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
913,10,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
913,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
913,12,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
913,13,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
913,14,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
913,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
913,16,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
913,17,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
913,18,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
913,19,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
913,20,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
913,21,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
914,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
914,2,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
915,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
916,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
917,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
918,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
919,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
919,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
919,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
919,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
919,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
919,6,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
919,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
920,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
921,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
922,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
922,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
922,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
923,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
924,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
924,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
925,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
926,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
927,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
928,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
929,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
929,2,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
930,1,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
931,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
932,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
932,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
933,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
933,2,Polyneuropathy chronic,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
933,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
934,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
935,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
935,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
935,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
935,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
935,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
935,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
935,7,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
935,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
935,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
936,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
937,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
938,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
939,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
940,1,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
941,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
941,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
941,3,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
941,4,Pancreatic failure,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
941,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
941,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
942,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
942,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
942,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
943,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
943,2,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
943,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
943,4,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
944,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
944,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
945,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
945,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
946,1,Headache,Headaches NEC,Headaches,Nerv,N
946,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
947,1,Device leakage,Device issues NEC,Device issues,Prod,N
947,2,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
947,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
948,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
949,1,Maternal exposure via partner during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
950,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
950,2,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
951,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
952,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
953,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
954,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
955,1,Device issue,Device issues NEC,Device issues,Prod,N
955,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
956,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
957,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
957,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
957,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
957,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
957,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
957,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
958,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
959,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
960,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
961,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
961,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
962,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
963,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
964,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
964,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
965,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
965,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
966,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
966,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
967,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
967,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
968,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
968,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
969,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
970,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
971,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
971,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
971,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
971,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
971,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
971,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
971,7,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
971,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
971,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
972,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
973,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
974,1,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
974,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
974,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
975,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
975,2,Headache,Headaches NEC,Headaches,Nerv,N
975,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
975,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
976,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
976,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
976,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
976,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
976,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
976,6,Headache,Headaches NEC,Headaches,Nerv,N
976,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
976,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
976,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
976,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
976,11,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
976,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
976,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
976,14,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
977,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
978,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
978,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
978,3,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
978,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
979,1,Maternal exposure via partner during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
980,1,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
981,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
982,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
983,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
984,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
985,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
986,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
986,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
987,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
988,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
989,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
989,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
989,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
989,4,Headache,Headaches NEC,Headaches,Nerv,N
989,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
989,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
990,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
990,2,Osteomyelitis chronic,Bone and joint infections,Infections - pathogen unspecified,Infec,N
991,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
991,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
991,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
991,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
992,1,Rebound psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
992,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
993,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
994,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
995,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
995,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
995,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
995,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
995,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
996,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
